PANDION THERAPEUTICS INC - COM (PAND)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COM
Total 13F shares
8,556,916
Share change
-2,034,622
Total reported value
$513,834,518
Price per share
$60.05
Number of holders
74
Value change
+$156,378,962
Number of buys
60
Number of sells
23

Institutional Holders of PANDION THERAPEUTICS INC - COM (PAND) as of Q1 2021

As of 31 Mar 2021, PANDION THERAPEUTICS INC - COM (PAND) was held by 74 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,556,916 shares. The largest 10 holders included BlackRock Inc., FEDERATED HERMES, INC., GOLDMAN SACHS GROUP INC, Versor Investments LP, Magnetar Financial LLC, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, ALPINE ASSOCIATES MANAGEMENT INC., Balyasny Asset Management LLC, and STATE STREET CORP. This page lists 74 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.